Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure - Top-Institutions - MDSpire

Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure

  • By

  • Joachim Boldt

  • July 9, 2026

  • 0 min

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    UAB–UC San Diego O’Brien Center for Acute Kidney Injury Research
    UAB–UC San Diego O’Brien Center for Acute Kidney Injury Research

    Birmingham, Alabama

    Key Differentiators

    • Acute Kidney Injury Research

  • #2

    University of Pittsburgh Medical Center (UPMC) – Center for Critical Care Nephrology
    University of Pittsburgh Medical Center (UPMC) – Center for Critical Care Nephrology

    Pittsburgh, Pennsylvania

    Key Differentiators

    • Critical Care Nephrology
    • Kidney Research

Original Source(s)

Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure

  • by Joachim Boldt

  • July 9, 2026

Related Content

Opioid-specific risk of respiratory depression in non-cancer pain: a retrospective cohort study

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

FDA Approves Dual-Energy Catheter Ablation Platform

The platform integrates with the CARTO ecosystem and enables physicians to use either pulsed field or radiofrequency energy based on patient anatomy and case complexity.